are cancer researchers Brian Druker, Nicholas Lydon, and Charles Sawyers become the Jon Hamms the world of science? Hamm, the suave star of the hit TV Mad Men is a perennial favorite to win the first prize Emmy award-TV act. Now, according to forecasts published today Druker, Lydon and Sawyers are among the best paris to win the most prestigious award-the Nobel months following science. But prognosticators note: despite its popularity among bettors this year, Hamm did not get his long awaited Emmy.
The predictions of Nobel Prize come from David Pendlebury, analyst with the scientific editor of Thomson Reuters, which operates the Web-based academic knowledge data. And he is not alone: A number of scientific blogs, including ChemBark and daily-Scientist have also thrown their favorite home medallions, which will be announced from October 3.
"This is the Oscars for nerds," says Paul Bracher, a chemist at the California Institute of Technology in Pasadena, which maintains the blog ChemBark chemistry on the subject.
Pendlebury began its tradition of picking the Nobel prize in 1989. He wrote an article for the magazine the Scientist detailing 20 probable peaks for future award in the category of physiology or medicine . it expanded to make the annual strokes in 02 in three other categories. chemistry, physics and economics "Since I wrote this article in 1989, there was only 2 years when we did not had at least one Nobel prize, "he said
predictions of Thomson Reuters team revolve around one thing.. citations Traversing Web of Knowledge, Pendlebury and his scientific colleagues Tally in key areas whose papers were returned most often by peers with some slaughter-locate scientists who still live and have made fundamental discoveries, for example-Pendlebury wrote a short catalog of "Citation Laureates". the men and women with a portfolio less the title winner.
Pendlebury would put his money on three cancer, particularly leukemia, researchers of winning the prize in physiology or medicine this year or in the coming years: Druker, the Health & Science University Portland Oregon; Lydon, formerly of Novartis Healthcare Company; and Sawyers of Memorial Sloan Kettering Cancer Center, New York City.
The trio was integral to the development of the drug imatinib and dasatinib, which closed some proteins that are responsible for the rapid division of cancer cells. Each also won a Lasker Award, often seen as the precursor to a win Nobel in 09.
But Bracher, who recently made similar predictions, suggests that only quotes may not be a good predictor. Nobel committees tend to watch science with simple, great discoveries to their names, he said-not necessarily researchers with the wider body of work. Bracher strews its own list of outstanding chemists with tongue-in-cheek ratings "Las Vegas style". It is betting that Stanford University chemist W. E. Moerner his favorite-6-1 that is missing from the list of Pendlebury will nab-physics or chemistry honor this year. Moerner pioneer an influential technique for studying single molecules such as proteins known as single molecule spectroscopy name.
Come October 5 Bracher said he hopes to live-blog the chemistry advertisements as it did last year. If that sounds a bit like the type of coverage the Oscars or Emmys get, the irony is not lost on him. "There is an element of ridicule that"
Yet forecasts n ' add suspense. "It makes it more exciting because you have written things, people made comments, and the fighting started," said all the days Scientific Sam Lord, a chemist at the University of California, Berkeley.
scientists at the top prediction charts, however, something in common with the smooth riding actors Emmy buzz. They try to stay humble Thomson Reuters provides biomedical engineer Robert Langer of the Massachusetts Institute of Technology in Cambridge could win for his work in regenerative medicine but Langer says simply.. "It is an honor to even be mentioned for something like that, but I would be very, very surprised to be selected"
0 Komentar